drugset / Trial / NCT03147066

Dezocine for Prevention of Catheter-related Bladder Discomfort

NCT03147066

Phase 4 Completed 96 enrolled Jianjun Yang
RandomizedParallel-groupDouble-blindPrevention

Summary

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

Timeline

Start
2017-09-01
Primary completion
2017-10-30
Completion
2017-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dezocine Other / unclassified 0.1 mg/kg Intravenous
Comparator flurbiprofen axetil Other / unclassified 1 mg/kg

Indications